文献速递肝肾功能剂量调整药物不良反应与药物警戒

二甲双胍治疗与乳酸酸中毒的关联:系统综述

The Association between Metformin Therapy and Lactic Acidosis.
PubMed 文献 · Drug Saf · 2019-01-01

该系统综述评估了二甲双胍治疗与乳酸酸中毒的关联,采用WHO-UMC和Naranjo因果关系评分系统分析已发表的559例病例。结果显示97%的病例存在独立危险因素,60%肾功能不全患者的处方剂量超过指南推荐,支持二甲双胍起贡献作用。

要点

  • 几乎所有二甲双胍相关乳酸酸中毒病例存在独立危险因素
  • 肾功能不全患者中60%处方剂量超指南推荐
  • 预测的入院前稳态血药浓度低于5 mg/L治疗上限

核心结论

  • 几乎全部二甲双胍相关乳酸酸中毒病例存在独立危险因素,支持二甲双胍起贡献作用。
  • 肾功能不全患者处方剂量平均超推荐1000 mg/天,但预测入院前血药浓度未超治疗范围。

研究设计与样本

  • 系统综述纳入已发表的二甲双胍相关乳酸酸中毒病例。
  • 共识别559例病例,采用WHO-UMC系统和Naranjo量表评估因果关系。

主要发现

  • 97%的病例呈现乳酸酸中毒的独立危险因素。
  • 肾功能不全患者中60%的处方剂量超过已发表指南推荐。
  • 预测的入院前二甲双胍稳态血药浓度低于5 mg/L的治疗范围上限。

关键数值与推荐

  • WHO-UMC系统和Naranjo量表用于因果关系评估。
  • 二甲双胍稳态血药浓度治疗范围上限为5 mg/L。
  • 肾功能不全患者处方剂量超指南推荐的比例为60%。

临床怎么用

  • 临床应评估二甲双胍使用者的乳酸酸中毒独立危险因素。
  • 肾功能不全患者需按指南调整二甲双胍剂量,避免超推荐用药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION AND OBJECTIVES: There is increasing evidence to suggest that therapeutic doses of metformin are unlikely to cause lactic acidosis. The aims of this research were (1) to formally evaluate the association between metformin therapy and lactic acidosis in published case reports using two causality scoring systems, (2) to determine the frequency of pre-existing independent risk factors in published metformin-associated lactic acidosis cases, (3) to investigate the association between risk factors and mortality in metformin-associated lactic acidosis cases, and (4) to explore the relationship between prescribed metformin doses, elevated metformin plasma concentrations and the development of lactic acidosis in cases with chronic renal impairment. METHODS: A systematic review was conducted to identify metformin-associated lactic acidosis cases. Causality was assessed using the World Health Organisation-Uppsala Monitoring Centre system and the Naranjo adverse drug reaction probability scale. Compliance to dosing guidelines was investigated for cases with chronic renal impairment as well as the association between steady-state plasma metformin concentrations prior to admission. RESULTS: We identified 559 metformin-associated lactic acidosis cases. Almost all cases reviewed (97%) presented with independent risk factors for lactic acidosis. The prescribed metformin dose exceeded published guidelines in 60% of cases in patients with impaired kidney function. Metformin steady-state plasma concentrations prior to admission were predicted to be below the proposed upper limit of the therapeutic range of 5 mg/L. CONCLUSIONS: Almost all cases of metformin-associated lactic acidosis reviewed presented with independent risk factors for lactic acidosis, supporting the suggestion that metformin plays a contributory role. The prescribed metformin dose, on average, exceeded the dosing recommendations by 1000 mg/day in patients with varying degrees of renal impairment but the predicted pre-admission plasma concentrations did not exceed the therapeutic range.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Kuan IHS, Savage RL, Duffull SB, et al. The Association between Metformin Therapy and Lactic Acidosis. Drug Saf. 2019. PMID: 31372935. doi:10.1007/s40264-019-00854-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。